| |
| | Chris Parsons - Frankfurt Memantine Alzheimer´s NMDA |
 | | Barnes, C., Danysz, W., and Parsons, C. G.; (1996) Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. |
 | | Danysz, W. and Parsons, C.G. (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease preclinical evidence. |
 | | Parsons, C. G., Danysz, W., and Quack, G.; (2000) Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - in vitro characterisation. |
| www.chrisparsons.de /Chris (2051 words) |
|